Description
A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Contact Person: Tanya Pozniansky
Please contact l: pozniat@sutterhealth.org about Adjuvant AFT-19
Location: PAMF (Peninsula/South Bay)
View study details on ClinicalTrials.govPrincipal Investigator
Co-Investigator(s)
Paula D. Kushlan, M.D., Edmund W. Tai, M.D., Glenn D. Wong, D.O., M. Dwight Chen, M.D., Priya Chakravarthi, M.D., Albert Pisani, M.D., Irene Wu, M.D., Natalia Colocci, M.D., Ph.D., David S. Leibowitz, M.D., FACP, Huan T. Ha, M.D., Monique de Bruin, M.D., MPH, Michael C. Wu, M.D., Janet Wang, M.D., Gillian L. Hsieh, M.D., Derrick Wong, M.D., Kim-Son Nguyen, M.D.
Recruitment Status
Active, Recruiting
Start Date
February 01, 2019
Related Studies
Genomic Health Oncotype DX AR-V7
Investigators: Nitin Rohatgi, MD, Kristin N. Arreola, M.D., Sivakumar Reddy, M.D., Rajeswari Chellappah, M.D., David S Yee, M.D., MPH, Brian K. Kim, M.D, Vijay Suhag, M.D., Kristie A. Bobolis, M.D.